CompanySCLX SCLXWNasdaqPalo Alto, CA

Scilex Holding Co

Scilex develops non-opioid pain management and neurodegenerative therapies.

SEC EDGAR ClinicalTrials.gov scilexholding.com

8-KSep 29Latest SEC filing

Sep 29Latest story

September 2026

Scilex expands Vivasor credit line to $30 million

Sep 29PartnershipScilex Holding Co

August 2026

Scilex extends $20 million credit line to related company Vivasor

Aug 12PartnershipScilex Holding Co

July 2026

Scilex confirms $12 million Vivasor stock repurchase deal in 8-K filing

Jul 22PartnershipScilex Holding Co

Scilex signs term sheet for $100 million investment from Kazakhstan's iHolding Group

Jul 6PartnershipScilex Holding Co